Latest filing published 23 Jan 2026 for Acumen Pharmaceuticals, Inc., €3,565.
Filing timeline
BuySaleInsider track record
Russell Barton: trading record in brief
This profile gathers the share dealings of Russell Barton in Acumen Pharmaceuticals, Inc. We count 13 filings; the first trade dates from 17 January 2023 and the latest from 22 January 2026.
No open-market purchase appears, only 9 sales worth €54k. The rest of the record consists of 4 share grants. Since January 2026: no purchases and 6 sales on the market.
Most recently, on 23 January 2026, the filings show an open-market sale worth €728 in Acumen Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Russell Barton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,315 shares@ US$1.8068.1% of flowCommon StockSEC:0001628280-26-003344:0
- 84,600 shares0Common StockSEC:0001628280-26-002958:0
- 3,530 shares@ US$1.858812.8% of flowCommon StockSEC:0001628280-26-001897:0
- 4,000 shares@ US$1.958115.2% of flowCommon StockSEC:0001628280-26-001261:0
- 2,914 shares@ US$1.610210.3% of flowCommon StockSEC:0001576885-25-000031:0
- 49,800 shares0Common StockSEC:0001576885-25-000013:1
- 7,636 shares@ US$1.862931.5% of flowCommon StockSEC:0001576885-25-000013:0
- 2,833 shares@ US$3.725822.1% of flowCommon StockSEC:0001576885-24-000024:0
- 73,000 shares0Common StockSEC:0001576885-24-000013:0
- 26,700 shares0Common StockSEC:0001209191-23-003731:0
10 of 10 declarations
